COMMUNIQUÉS West-GlobeNewswire

-
SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
13/05/2025 -
Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/2025 -
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025
13/05/2025 -
Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
13/05/2025 -
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
13/05/2025 -
Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update
13/05/2025 -
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
13/05/2025 -
Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/2025 -
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer
13/05/2025 -
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
13/05/2025 -
Tempest Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/2025 -
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
13/05/2025 -
Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results
13/05/2025 -
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
13/05/2025 -
Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/2025 -
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2025
13/05/2025 -
Applied Therapeutics Reports First Quarter 2025 Financial Results
13/05/2025 -
Claritas Neurocloud™ for Brain Imaging Analysis to Commence Commercialization on Execution of Partnership between Claritas and Qubiotech
13/05/2025 -
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update
13/05/2025
Pages